Why Invest | Alliance Pharma

Alliance in numbers

A proven track record

20+ Years of operation

34.1 £m Free cash flow (2020)

-5% See through revenue growth (2020)

68% Of revenue from consumer healthcare products (2020)

15 Acquisitions in past ten years

INVESTMENT CASE

Investors achieve more with Alliance

With a proven track record Alliance is committed to delivering sustained growth and value for investors.

Recognised expertise

• Deep sector expertise in the management of many types of consumer healthcare and prescription medicine
products
• Engaged and committed people
• Expertise in sourcing, executing and integrating acquisitions

About us

Clearly articulated strategy

Enabling delivery of sustainable business growth through:

• Maximising brand potential to deliver organic growth
• Acquiring new products to deliver incremental growth
• Investing in people
• Acting responsibly

Our strategy

Diversified portfolio reduces risk

• Revenues derive from around 80 Consumer Healthcare brands and Prescription Medicines spanning multiple therapy areas and geographies

Our brands

Strong financial performance

• Highly profitable and cash generative
• Established track record of delivering underlying profit growth and effectively managing our borrowing
commitments
• Strong cash generation supports deal flow and enables rapid deleveraging post acquisition

Financial highlights

Sustainable business commitments

• Purpose-driven organisation, with a strong collaborative culture and well-established values
• Well-invested infrastructure
• Committed to ethical and sustainable business practices

Why partner with alliance